CCR5 genotype and resistance to vertical transmission of HIV-1

Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology

Volumn 21, Issue 3, 1999, Pages 189-193

  Philpott, Sean ^a   Burger, Harold ^a,b   Charbonneau, Tina ^a   Grimson, Roger ^c   Vermund, Sten H ^d   Visosky, Aloise ^a   Nachman, Sharon ^c   Kovacs, Andrea ^e   Tropper, Pamela ^f   Frey, Henry ^g   Weiser, Barbara ^a,b  

^a WADSWORTH CENTER   (United States)

^b ALBANY MEDICAL COLLEGE   (United States)

^c STONY BROOK UNIVERSITY   (United States)

^d UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^e UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^f The New York Presbyterian Hospital   (United States)

^g St John's Riverside Hospital   (United States)

Author keywords

CCR5; HIV 1; Vertical transmission

Indexed keywords

CHEMOKINE RECEPTOR CCR5;

ARTICLE; CHILD; CONTROLLED STUDY; GENE FREQUENCY; GENE MUTATION; GENOTYPE; HOMOZYGOTE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION RESISTANCE; INFECTION SENSITIVITY; MAJOR CLINICAL STUDY; PREVALENCE; PRIORITY JOURNAL; UNITED STATES; VERTICAL TRANSMISSION; VIRUS TRANSMISSION;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; PIERINAE; RNA VIRUSES;

EID: 0033166190     PISSN: 10779450     EISSN: None     Source Type: Journal    
DOI: 10.1097/00126334-199907010-00002     Document Type: Article

References (24)

1. D'Souza MP, Harden VA. Chemokines and HIV-1 second receptors. Nat Med 1996;2:1293-1300.
2. Moore JP, Trkola A, Dragic T. Co-receptors for HIV-1 entry. Curr Opin Immunol 1997;9:551-62.
3. Berger EA. Introduction: HIV-1 co-receptors solve old questions and raise many new ones. Semin Immunol 1998;10:165-8.
4. Liu R, Paxton WA, Choe S, et al. Homozygous detect in HIV-1 co-receptor accounts for resistance for some multiply-exposed individuals to HIV-1 infection. Cell 1996;86:367-77.
5. Samson M, Libert F, Doranz BJ, et al. Resistance to HIV-1 infection in Caucasian individuals bearing mutant alleles of the CCR-5 chemokine receptor gene. Nature 1996;382:722-5.
6. Dean M, Carrington M, Winkler C, et al. Genetic restriction of HIV-1 infection and progression to AIDS by a deletion allele of the CKR5 structural gene. Science 1996;273:1856-62.
7. Huang Y, Paxton WA, Wolinsky SM, et al. The role of a mutant CCR5 allele in HIV-1 transmission and disease progression. Nat Med 1996;2:1240-3.
8. Scarlatti G. Paediatric HIV infection. Lancet 1996;348:863-8.
9. Fang G, Burger H, Grimson R, et al. Maternal plasma HIV-1 RNA level: a determinant and projected threshold for mother-to-child transmission. Proc Natl Acad Sci USA 1995;2:12100-4.
10. Dickover RE, Garratty EM, Herman SA, et al. Identification of levels of maternal HIV-1 RNA associated with risk of perinatal transmission. JAMA 1996;257:599-605.
11. Shaffer N, Roongpisuthipong A, Siriwasin W, et al. Maternal virus load and perinatal human immunodeficiency virus type 1 subtype E transmission, Thailand. J Infect Dis 1999;179:590-9.
12. Shaffer N, Chuachoowong R, Mock P, et al. Short-course zidovudine for perinatal HIV-1 transmission in Bangkok, Thailand. Lancet 1999;353:773-80.
13. Mayaux MJ, Blanche S, Rouzioux C, et al. Maternal factors associated with perinatal HIV-1 transmission: the French Cohort Study; 7 years of follow-up observation. J Acquir Immune Defic Syndr Hum Retrovirol 1995;8:188-94.
14. Rousseau CM, Just JJ, Abrams EJ, et al. CCR5del32 in perinatal HIV-1 infection. J Acquir Immune Defic Syndr Hum Retrovirol 1997;16:239-42.
15. Edelstein RE, Manns Arcuino LA, Hughes JP, et al. Risk of mother-to-infant transmission of HIV-1 is not reduced in CCR5/ Δ32ccr5 heterozygotes. J Acquir Immune Defic Syndr Hum Retrovirol 1997;16:243-6.
16. Misrahi M, Teglas J-P, N'Go N, et al. CCR-5 chemokine receptor variant in HIV-1 mother-to-child transmission and disease progression in children. JAMA 1998;279:277-80.
17. Mandl CW, Aberle SE, Henkel JH, et al. Possible influence of the mutant CCR5 allele on vertical transmission of HIV-1. J Med Virol 1998;55:51-5.
18. Shearer WT, Kalish LA, Zimmerman PA. CCR5 HIV-1 vertical transmission. Women and Infants Transmission Study group. J Acquir Immune Defic Syndr Hum Retrovirol 1998;17:180.
19. Charbonneau TT, Wade NA, Wiener L, et al. Vertical transmission of HIV in New York State: a basis for statewide testing of newborns. AIDS Patient Care Sex Transm Dis 1997;11:227-36.
20. Kovacs A, Xu J, Rasheed S, et al. Comparison of a rapid nonisotopic polymerase chain reaction assay with four commonly used methods for the early diagnosis of HIV-1 infection in neonates and children. Pediatr Infect Dis J 1995;14:948-54.
21. Connor EM, Sperling RS, Gelber R, et al. Reduction of maternal-infant transmission of HIV-1 with zidovudine treatment. N Engl J Med 1994;18:1173-80.
22. Cavalli-Sforza LL, Bodmer WF. The genetics of human populations. San Francisco: WH Freeman, 1971.
23. Michael NL, Chang G, Louie LG, et al. The role of viral phenotype and CCR-5 gene defects in HIV-1 transmission and disease progression. Nat Med 1997;3:338-40.
24. D'Aquila RT, Sutton L, Savara A, et al. CCR5/Δccr5 heterozygosity: a selective pressure for the syncytium-inducing HIV-1 phenotype. J Infect Dis 1998;177:1549-53.